×
返回 Agenda
Session Chair(s)
Jian Peng
Clinical Research Director
Sanofi (China), China
Speaker(s)
CDE Reviewer’s View on FIM Studies
Representative Invited
CDE, Taiwan
Regulatory Requirements for FIM Clinical Studies Focus on GCP, CFDA
Representative Invited
China
Case Studies of FIH on Innovative Drug Development in China
Representative Invited
United States